SMTL ID : 9csk.2 (1 other biounit)

Crystal structure of CDK4 cyclin D1 in complex with atirmociclib

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.25 Å

Oligo State

hetero-1-1-mer

Ligands

1 x 01: Atirmociclib

01.1: 13 residues within 4Å: Chain B: I.12, Y.17, V.20, A.33, K.35, F.90, E.91, H.92, V.93, E.141, L.144, D.155, Y.162 10 PLIP interactions: 10 interactions with chain B Hydrophobic interactions: B:I.12, B:Y.17, B:V.20, B:A.33, B:L.144 Hydrogen bonds: B:K.35, B:V.93, B:V.93, B:D.96, B:D.155

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Palmer, C.L. et al., CDK4 selective inhibition improves preclinical anti-tumor efficacy and safety. Cancer Cell (2025)

Release Date

2025-03-26

Peptides

G1/S-specific cyclin-D1: A
Cyclin-dependent kinase 4: B

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
C

B
D

G1/S-specific cyclin-D1

Cyclin-dependent kinase 4

Related Entries With Identical Sequence